These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Biochemical characterization of some pyrazolopyrimidine-based inhibitors of xanthine oxidase. Tamta H; Kalra S; Mukhopadhyay AK Biochemistry (Mosc); 2006; 71 Suppl 1():S49-54. PubMed ID: 16487068 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of plant growth regulators on xanthine oxidase. Sheu SY; Chiang HC Anticancer Res; 1996; 16(1):311-5. PubMed ID: 8615627 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition. Joshi G; Sharma M; Kalra S; Gavande NS; Singh S; Kumar R Bioorg Chem; 2021 Feb; 107():104620. PubMed ID: 33454509 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the xanthine oxidase inhibitory activity of alk(en)yl phenols and related compounds. Masuoka N; Kubo I Phytochemistry; 2018 Nov; 155():100-106. PubMed ID: 30096514 [TBL] [Abstract][Full Text] [Related]
10. Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation. Sabán-Ruiz J; Alonso-Pacho A; Fabregate-Fuente M; de la Puerta González-Quevedo C Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):94-9. PubMed ID: 23286293 [TBL] [Abstract][Full Text] [Related]
11. Targeting Xanthine Oxidase by Natural Products as a Therapeutic Approach for Mental Disorders. Martorell M; Lucas X; Alarcón-Zapata P; Capó X; Quetglas-Llabrés MM; Tejada S; Sureda A Curr Pharm Des; 2021; 27(3):367-382. PubMed ID: 32564744 [TBL] [Abstract][Full Text] [Related]
14. 2-styrylchromones as novel inhibitors of xanthine oxidase. A structure-activity study. Fernandes E; Carvalho F; Silva AM; Santos CM; Pinto DC; Cavaleiro JA; Bastos Mde L J Enzyme Inhib Med Chem; 2002 Feb; 17(1):45-8. PubMed ID: 12365460 [TBL] [Abstract][Full Text] [Related]
15. 3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor. Niu Y; Zhu H; Liu J; Fan H; Sun L; Lu W; Liu X; Li L Chem Biol Interact; 2011 Feb; 189(3):161-6. PubMed ID: 21167141 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors. Sato D; Kisen T; Kumagai M; Ohta K Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704 [TBL] [Abstract][Full Text] [Related]
17. In vitro effects of novel type M-V-O derivatives on Xanthine Oxidase. Kaya MO; Gül GÇK; Kurtuluş F Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):25-28. PubMed ID: 29307337 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold. Tang HJ; Li W; Zhou M; Peng LY; Wang JX; Li JH; Chen J Eur J Med Chem; 2018 May; 151():849-860. PubMed ID: 29684895 [TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen. Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820 [TBL] [Abstract][Full Text] [Related]
20. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors. Nepali K; Singh G; Turan A; Agarwal A; Sapra S; Kumar R; Banerjee UC; Verma PK; Satti NK; Gupta MK; Suri OP; Dhar KL Bioorg Med Chem; 2011 Mar; 19(6):1950-8. PubMed ID: 21353569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]